Systematic review of factors affecting the ratios of morphine and its major metabolites.
about
Oral morphine for cancer painOral morphine for cancer painOral morphine for cancer painTolerance and withdrawal from prolonged opioid use in critically ill children.A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer PatientsPharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal.Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairmentInfluences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.Predicting response to lithium in mood disorders: role of genetic polymorphisms.Role of morphine's metabolites in analgesia: concepts and controversies.Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study.A novel metabolic pathway of morphine: formation of morphine glucosides in cancer patients.Recent advances in neonatal pharmacotherapy.Case files of the University of Massachusetts fellowship in medical toxicology: lethal dose of opioids contained in an elastomeric capsule labeled as vancomycin.Opioid analgesia in neonates following cardiac surgery.Post-mortem clinical pharmacology.Pharmacokinetics of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Terminally Ill Adult Patients.Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6∗2, 1A7∗12, 1A8∗3, 1A9∗3, 2B7∗2, and 2B15∗2) in a Saudi population.Morphine for chronic neuropathic pain in adults.Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidol.Opioids for cancer pain - an overview of Cochrane reviews.Oral morphine dosing predictions based on single dose in healthy children undergoing surgery.Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period.Morphine or oxycodone in cancer pain?Design, synthesis, and evaluation of biotinylated opioid derivatives as novel probes to study opioid pharmacology.Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache.Opioid tolerance in neonates: a state-of-the-art review.Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.Direct and efficient liquid chromatographic-tandem mass spectrometric method for opiates in urine drug testing - importance of 6-acetylmorphine and reduction of analytes.Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat.Morphine-related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administration.
P2860
Q24185873-EC2F57E8-C0A0-40D4-88A6-0AA1686769C4Q24201079-E5EC8767-B219-42E3-8447-6CBA6830CF0DQ24243158-7F8357AD-D31E-4FC8-9148-2A2BF81C3F68Q30428413-925674E2-DC80-4415-827B-2A20A61EDC76Q33845632-824E8DD7-F74D-498A-A647-A82796CD7679Q34487629-7AF66F21-C8C6-4C82-8E64-A8338A5AD38AQ34580479-B6BFECF8-2C0D-4DF4-8A2B-BDC99EDCE551Q34608990-3BBBC349-B80E-4422-910D-9497223AFA2CQ34792547-07A010FC-C71D-4F3D-A9A6-654B5DA957F1Q35058020-EBE5B3D1-9881-4C44-9C65-CEE5C1E300B8Q35594877-14207FDF-35FC-4F21-AD10-0FA1E91FBB96Q35823710-F8980C9B-0AED-4DEC-888E-847C241E68D8Q35825302-20B6F8A7-8C3A-485D-86EF-5C91822806E0Q36434300-3E37D0E4-61C2-46FC-AFAF-A8BA7A4A47EDQ36548408-53EC6D2B-5E14-4C73-A26B-61805CD619E0Q36813077-C36C7320-191E-4DCC-A7A0-5E605FA4C198Q36922235-93E13A1B-7C5E-46C9-9D18-7DC5B83F0417Q36924082-4E84F71D-D1FA-40B8-8DF0-10A4D6028496Q37707406-9874B3DE-9399-4D2A-AD9E-74AEB2EE385CQ38771530-205D5129-FB9A-4318-8D61-F1D82B98992CQ38809021-1C7F10EE-30AA-45DA-AA7E-9A38559EF598Q39153206-1BDCCCFE-4C7F-4973-A80A-BB4DFFBEFF29Q39251483-C3468A3B-77B3-4BFA-AA89-0A23619B059DQ39280262-9D518B89-7E38-4859-BBB0-300E266CE014Q39421912-7001B007-7D38-4CCC-8BA7-FC9BD0879A8FQ39904129-28684B4A-1F0C-442A-A4F8-CDFB902802BAQ42171215-4966B8D6-669E-4B2C-A1F8-7ABDCBE1C1C0Q43069472-B9C045AB-B73B-46E0-884C-78921BB00386Q43856272-35E83D5C-2D43-4AEE-AC93-37609B9A99E1Q44476215-7ED7018A-7560-4D95-BE7D-108723222CDDQ46579032-C97D07C7-2AE8-40F2-8971-0BE3AB064D20Q46702686-91366BF6-4C0B-4320-8F15-CEE63FF2E7BCQ52278255-193EA820-65CA-4FC7-B793-CD5465AB7D84
P2860
Systematic review of factors affecting the ratios of morphine and its major metabolites.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Systematic review of factors affecting the ratios of morphine and its major metabolites.
@en
type
label
Systematic review of factors affecting the ratios of morphine and its major metabolites.
@en
prefLabel
Systematic review of factors affecting the ratios of morphine and its major metabolites.
@en
P2093
P31
P1433
P1476
Systematic review of factors affecting the ratios of morphine and its major metabolites.
@en
P2093
H J McQuay
S L Collins
P356
10.1016/S0304-3959(97)00142-5
P407
P577
1998-01-01T00:00:00Z